Bio Financial Statements From 2010 to 2024

BIO Stock  USD 300.41  0.04  0.01%   
Bio Rad financial statements provide useful quarterly and yearly information to potential Bio Rad Laboratories investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Bio Rad financial statements helps investors assess Bio Rad's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Bio Rad's valuation are summarized below:
Gross Profit
1.6 B
Profit Margin
(0.24)
Market Capitalization
8.8 B
Enterprise Value Revenue
3.2048
Revenue
2.7 B
We have found one hundred twenty available fundamental signals for Bio Rad Laboratories, which can be analyzed and compared to other ratios and to its rivals. Self-guided Investors are advised to validate Bio Rad's prevailing fundamentals against the trend between 2010 and 2024 to make sure the company can sustain itself down the road. As of the 16th of April 2024, Market Cap is likely to grow to about 919.2 M. Also, Enterprise Value is likely to grow to about 1 B

Bio Rad Total Revenue

1.38 Billion

Check Bio Rad financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bio main balance sheet or income statement drivers, such as Depreciation And Amortization of 202 M, Interest Expense of 51.9 M or Selling General Administrative of 481.6 M, as well as many exotic indicators such as Price To Sales Ratio of 3.71, Dividend Yield of 11.14 or PTB Ratio of 2.15. Bio financial statements analysis is a perfect complement when working with Bio Rad Valuation or Volatility modules.
  
This module can also supplement Bio Rad's financial leverage analysis and stock options assessment as well as various Bio Rad Technical models . Check out the analysis of Bio Rad Correlation against competitors.

Bio Rad Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets12.9 B12.3 B7.2 B
Slightly volatile
Short and Long Term Debt Total1.5 B1.4 B577 M
Slightly volatile
Total Current Liabilities338.4 M522.8 M492.7 M
Slightly volatile
Total Stockholder Equity9.2 B8.7 B5.1 B
Slightly volatile
Property Plant And Equipment Net759.9 M723.7 M521.4 M
Slightly volatile
Retained Earnings9.7 B9.3 B4.8 B
Slightly volatile
Cash257.1 M404 M427.1 M
Pretty Stable
Non Current Assets Total9.7 B9.3 B5.2 B
Slightly volatile
Cash And Short Term Investments1.7 B1.6 B959.1 M
Slightly volatile
Net Receivables272.8 M500.9 M383.1 M
Slightly volatile
Common Stock Shares Outstanding29.1 M29.2 M28.9 M
Slightly volatile
Liabilities And Stockholders Equity12.9 B12.3 B7.2 B
Slightly volatile
Non Current Liabilities Total3.2 BB1.6 B
Slightly volatile
Inventory819.5 M780.5 M542.5 M
Slightly volatile
Other Current Assets91.6 M154 M132.4 M
Very volatile
Total Liabilities3.7 B3.6 B2.1 B
Slightly volatile
Property Plant And Equipment Gross1.9 B1.8 B825.9 M
Slightly volatile
Total Current Assets3.2 BBB
Slightly volatile
Short Term Debt30.8 M41.4 M34.4 M
Pretty Stable
Accounts Payable138.4 M142.8 M225.4 M
Slightly volatile
Intangible Assets188.7 M320.5 M212.2 M
Slightly volatile
Common Stock Total Equity2.6 K2.7 K836 K
Slightly volatile
Common Stock2.6 K2.7 K836.1 K
Slightly volatile
Other Assets73.6 M85.1 M85 M
Slightly volatile
Long Term Debt1.3 B1.2 B531.5 M
Slightly volatile
Good Will339.1 M413.6 M389 M
Pretty Stable
Property Plant Equipment371.9 M573.4 M453.5 M
Slightly volatile
Current Deferred Revenue37.5 B35.8 B4.9 B
Slightly volatile
Other Liabilities2.4 B2.3 B1.1 B
Slightly volatile
Short Term Investments1.3 B1.2 B532 M
Slightly volatile
Net Tangible Assets11.1 B10.6 B5.4 B
Slightly volatile
Capital Surpluse366.5 M514.6 M339.4 M
Slightly volatile
Non Current Liabilities Other219.8 M195.1 M195 M
Slightly volatile
Deferred Long Term Asset Charges15.6 M17.8 M15.5 M
Slightly volatile
Long Term Debt Total1.1 B1.1 B550.4 M
Pretty Stable
Long Term Investments5.1 B7.7 B3.8 B
Slightly volatile
Short and Long Term Debt461.7 K486 K203 M
Slightly volatile
Cash And Equivalents549.9 M499.3 M485.8 M
Slightly volatile
Net Invested CapitalB9.9 BB
Slightly volatile
Net Working Capital1.9 B2.5 B1.6 B
Slightly volatile
Capital Stock2.4 K2.7 K2.9 K
Slightly volatile
Capital Lease Obligations165 M205.9 M206.6 M
Slightly volatile

Bio Rad Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization202 M192.4 M144.8 M
Slightly volatile
Selling General Administrative481.6 M846.8 M727.6 M
Slightly volatile
Total Revenue1.4 B2.7 B2.1 B
Slightly volatile
Gross Profit769.3 M1.4 B1.2 B
Slightly volatile
Other Operating Expenses1.2 B2.3 B1.9 B
Slightly volatile
EBIT403 M383.8 M267.4 M
Slightly volatile
EBITDA605 M576.2 M412.2 M
Slightly volatile
Cost Of Revenue1.3 B1.2 B992.5 M
Slightly volatile
Total Operating Expenses613.7 MB925.7 M
Slightly volatile
Research Development161.8 M226.9 M203.8 M
Slightly volatile
Minority Interest18 K18.9 K112.4 K
Slightly volatile
Non Operating Income Net Other54.1 M51.5 M21 M
Slightly volatile
Non Recurring353.2 M336.4 M173.3 M
Slightly volatile
Interest Income91.6 M96.4 M658.1 M
Slightly volatile
Reconciled Depreciation111.4 M144.2 M141.8 M
Slightly volatile
Extraordinary Items47.6 M44.1 M59.8 M
Slightly volatile
Selling And Marketing Expenses1.2 M1.3 M1.5 M
Slightly volatile

Bio Rad Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow271.2 M434.2 M462.2 M
Very volatile
Depreciation202 M192.4 M137 M
Slightly volatile
Capital Expenditures84.5 M156.7 M113 M
Pretty Stable
Total Cash From Operating Activities393.7 M374.9 M296.1 M
Slightly volatile
End Period Cash Flow286.4 M404 M429.5 M
Pretty Stable
Change Receivables82.3 M78.4 M30.2 M
Slightly volatile
Cash Flows Other Operating137.9 M145.2 M264.1 M
Very volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio3.713.53073.2598
Slightly volatile
Dividend Yield11.1410.61371.9648
Slightly volatile
PTB Ratio2.151.0791.8203
Slightly volatile
Days Sales Outstanding87.3568.445168.7718
Pretty Stable
Book Value Per Share314299174
Slightly volatile
Invested Capital0.130.14080.2061
Slightly volatile
Operating Cash Flow Per Share13.4812.836610.0993
Slightly volatile
PB Ratio2.151.0791.8203
Slightly volatile
EV To Sales4.13.90573.3257
Slightly volatile
Inventory Turnover2.191.58861.9156
Pretty Stable
Days Of Inventory On Hand149230191
Pretty Stable
Payables Turnover6.598.68145.0755
Pretty Stable
Sales General And Administrative To Revenue0.430.420.3787
Pretty Stable
Research And Ddevelopement To Revenue0.10.0850.0949
Pretty Stable
Cash Per Share57.9855.217732.7398
Slightly volatile
POCF Ratio15.1825.153926.5811
Slightly volatile
Days Payables Outstanding54.5742.044182.724
Pretty Stable
EV To Operating Cash Flow17.427.826227.5784
Slightly volatile
Intangibles To Total Assets0.05670.05970.1242
Slightly volatile
Current Ratio6.125.83084.0248
Slightly volatile
Tangible Book Value Per Share288274153
Slightly volatile
Receivables Turnover3.785.33275.3629
Pretty Stable
Graham Number402383345
Slightly volatile
Shareholders Equity Per Share314299174
Slightly volatile
Debt To Equity0.130.14080.2061
Slightly volatile
Revenue Per Share96.0391.453475.581
Slightly volatile
Interest Debt Per Share46.0243.830920.0604
Slightly volatile
Debt To Assets0.09510.10010.1206
Slightly volatile
Enterprise Value Over EBITDA9.818.107117.5622
Slightly volatile
Short Term Coverage Ratios8.619.0643387
Very volatile
Operating Cycle292298264
Slightly volatile
Price Book Value Ratio2.151.0791.8203
Slightly volatile
Days Of Payables Outstanding54.5742.044182.724
Pretty Stable
Price To Operating Cash Flows Ratio15.1825.153926.5811
Slightly volatile
Company Equity Multiplier2.191.4071.5858
Slightly volatile
Long Term Debt To Capitalization0.110.11980.1408
Slightly volatile
Total Debt To Capitalization0.120.12340.1532
Slightly volatile
Debt Equity Ratio0.130.14080.2061
Slightly volatile
Quick Ratio4.254.04322.6565
Slightly volatile
Net Income Per E B T0.580.74970.7564
Very volatile
Cash Ratio0.410.77270.8171
Pretty Stable
Cash Conversion Cycle225256185
Pretty Stable
Operating Cash Flow Sales Ratio0.080.14040.1212
Slightly volatile
Days Of Inventory Outstanding149230191
Pretty Stable
Days Of Sales Outstanding87.3568.445168.7718
Pretty Stable
Cash Flow Coverage Ratios0.290.30467.0757
Slightly volatile
Price To Book Ratio2.151.0791.8203
Slightly volatile
Fixed Asset Turnover5.533.69094.7057
Slightly volatile
Price Cash Flow Ratio15.1825.153926.5811
Slightly volatile
Enterprise Value Multiple9.818.107117.5622
Slightly volatile
Debt Ratio0.09510.10010.1206
Slightly volatile
Cash Flow To Debt Ratio0.290.30467.0757
Slightly volatile
Price Sales Ratio3.713.53073.2598
Slightly volatile
Asset Turnover0.210.21720.4842
Slightly volatile
Gross Profit Margin0.630.53580.5575
Pretty Stable
Price Fair Value2.151.0791.8203
Slightly volatile

Bio Rad Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap919.2 M875.4 M906.2 M
Slightly volatile
Enterprise ValueB952.4 M987.1 M
Slightly volatile

Bio Fundamental Market Drivers

Forward Price Earnings26.9542
Cash And Short Term Investments1.6 B

Bio Upcoming Events

15th of February 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
15th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Bio Rad Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Bio Rad income statement, its balance sheet, and the statement of cash flows. Bio Rad investors use historical funamental indicators, such as Bio Rad's revenue or net income, to determine how well the company is positioned to perform in the future. Although Bio Rad investors may use each financial statement separately, they are all related. The changes in Bio Rad's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Bio Rad's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Bio Rad Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Bio Rad. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue35.8 B37.5 B
Total Revenue2.7 B1.4 B
Cost Of Revenue1.2 B1.3 B
Stock Based Compensation To Revenue 0.02  0.02 
Sales General And Administrative To Revenue 0.42  0.43 
Research And Ddevelopement To Revenue 0.08  0.10 
Capex To Revenue(0.06)(0.06)
Revenue Per Share 91.45  96.03 
Ebit Per Revenue 0.14  0.08 
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Bio Rad in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Bio Rad's short interest history, or implied volatility extrapolated from Bio Rad options trading.

Pair Trading with Bio Rad

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bio Rad position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Rad will appreciate offsetting losses from the drop in the long position's value.

Moving against Bio Stock

  0.63VALN Valneva SE ADR Financial Report 2nd of May 2024 PairCorr
  0.57BNR Burning Rock BiotechLtd Financial Report 4th of June 2024 PairCorr
  0.42ELYM Eliem Therapeutics TrendingPairCorr
The ability to find closely correlated positions to Bio Rad could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bio Rad when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bio Rad - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bio Rad Laboratories to buy it.
The correlation of Bio Rad is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bio Rad moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bio Rad Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bio Rad can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Bio Rad Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Rad's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Rad Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Rad Laboratories Stock:
Check out the analysis of Bio Rad Correlation against competitors.
You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Complementary Tools for Bio Stock analysis

When running Bio Rad's price analysis, check to measure Bio Rad's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Rad is operating at the current time. Most of Bio Rad's value examination focuses on studying past and present price action to predict the probability of Bio Rad's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Rad's price. Additionally, you may evaluate how the addition of Bio Rad to your portfolios can decrease your overall portfolio volatility.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Transaction History
View history of all your transactions and understand their impact on performance
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Is Bio Rad's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Rad. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Rad listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.56)
Earnings Share
(21.81)
Revenue Per Share
91.453
Quarterly Revenue Growth
(0.07)
Return On Assets
0.0177
The market value of Bio Rad Laboratories is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Rad's value that differs from its market value or its book value, called intrinsic value, which is Bio Rad's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Rad's market value can be influenced by many factors that don't directly affect Bio Rad's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bio Rad's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Rad is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Rad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.